NovoCure Limited (NVCR) has a MoatMap StockRank of 13/100 based on Quality (38/100), Value (43/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL. NovoCure, a medical device company with a 'SELL' signal and no clear macro tailwind, represents a speculative investment rather than a quality compounder.